Anaplastic (Malignant) Meningioma
1 clinical trials · Condition
◉ Watch Anaplastic (Malignant) Meningioma
| Record | Firm | Date |
|---|---|---|
| Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma (NCT02847559) | Northwestern University | 2016-08-01 |
Track Anaplastic (Malignant) Meningioma automatically
Every clearance here is in the API, with alerts when new ones post.